14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 18, 2024 Buy 18 000 Catlin Michael Restricted Stock Award
Mar 18, 2024 Buy 18 000 Misajon Pamela Restricted Stock Award
Mar 18, 2024 Buy 18 000 Nagel Michael Restricted Stock Award
Oct 05, 2023 Buy 65 600 Bersani Pietro Restricted Stock Units
Oct 05, 2023 Buy 7 500 Misajon Pamela Restricted Stock Units
Oct 05, 2023 Buy 18 000 Nagel Michael Restricted Stock Units
Oct 05, 2023 Buy 7 500 Catlin Michael Restricted Stock Units
Oct 05, 2023 Buy 21 900 Hungerford Brian Restricted Stock Units
Oct 01, 2023 Buy 0 Hungerford Brian
Jul 20, 2023 Buy 0 Catlin Michael
Jul 20, 2023 Buy 0 Misajon Pamela
Aug 11, 2022 Buy 50 000 Dahlbeck Scott Common Stock
Aug 11, 2022 Buy 50 000 Clark Daniel Grant Common Stock
Aug 11, 2022 Buy 638 298 Bersani Pietro Common Stock
Jun 30, 2022 Buy 183 600 Nagel Michael Stock Option (Right to Buy)
Jun 30, 2022 Buy 183 600 Cicchetti Americo Stock Option (Right to Buy)
Jun 30, 2022 Buy 183 600 Tirelli Francis X Stock Option (Right to Buy)
Jun 30, 2022 Buy 183 600 Reeves Karen Stock Option (Right to Buy)
May 23, 2022 Buy 17 240 Dahlbeck Scott Common Stock
Feb 14, 2022 Buy 0 Reeves Karen
Jan 28, 2022 Buy 0 Tirelli Francis X
Sep 30, 2021 Buy 0 Clark Daniel Grant Restricted Stock Units
Sep 30, 2021 Buy 0 Clark Daniel Grant Common Stock
Sep 30, 2021 Buy 5 152 Clark Daniel Grant Stock Option (right to buy)
Sep 09, 2021 Buy 2 800 Chiriva Internati Maurizio Common Stock
Jul 13, 2021 Buy 50 189 Ryan Michael Charles Common Stock
Jul 12, 2021 Buy 31 991 Ryan Michael Charles Restricted Stock Units
Jul 01, 2021 Buy 2 863 Ryan Michael Charles Stock Options
Jun 22, 2021 Buy 71 985 Rotino Gianluca Restricted Stock Units
Jun 22, 2021 Buy 147 038 Nunez Ignacio Employee Stock Option (right to buy)
Jun 22, 2021 Buy 17 710 Nunez Ignacio Restricted Stock Units
Jun 07, 2021 Buy 0 Nunez Ignacio
May 24, 2021 Buy 5 000 Schneider Jerry A. Common Stock
Dec 18, 2020 Sell 4 423 Rotino Gianluca Employee Stock Option (right to buy)
Dec 18, 2020 Sell 5 528 Tontat Tony Employee Stock Option (right to buy)
Dec 18, 2020 Buy 5 528 Tontat Tony Employee Stock Option (right to buy)
Dec 18, 2020 Buy 4 423 Rotino Gianluca Employee Stock Option (right to buy)
Oct 20, 2020 Buy 5 278 Schneider Jerry A. Stock Options
Oct 20, 2020 Buy 5 278 Nagel Michael Stock Options
Oct 15, 2020 Buy 0 Tontat Tony Common Stock
Oct 15, 2020 Buy 186 135 Tontat Tony Restricted Stock Units
Oct 15, 2020 Buy 8 587 Tontat Tony Stock Options
Oct 15, 2020 Buy 57 241 Tontat Tony Stock Options
Oct 15, 2020 Buy 0 Chiriva Internati Maurizio Common Stock
Oct 15, 2020 Buy 475 018 Chiriva Internati Maurizio Restricted Stock Units
Oct 15, 2020 Buy 0 Dahlbeck Scott Common Stock
Oct 15, 2020 Buy 17 240 Dahlbeck Scott Restricted Stock Units
Oct 15, 2020 Buy 0 Rotino Gianluca Common Stock
Oct 15, 2020 Buy 186 135 Rotino Gianluca Restricted Stock Units
Oct 15, 2020 Buy 5 278 Cicchetti Americo Stock Options
Oct 15, 2020 Buy 5 278 Bersani Pietro Stock Options
Jun 08, 2020 Buy 14 311 Dahlbeck Scott Stock Options
Nov 10, 2017 Buy 147 806 Rotino Gianluca Stock Options
INSIDER POWER
93.799
Last 53 transactions
Buy: 3 122 702 | Sell: 9 951 (Shares)

Based on the 53 latest insides trades, we have calculated the insider power to be positive at a ratio of 93.799.

In total, the insiders bought 3 122 702 and sold 9 951 KRBP shares in the last 53 trades.

Click to get the best stock tips daily for free!

About Kiromic BioPharma, Inc.

Kiromic BioPharma. Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candi... KRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT